Study identifier:5077IL/0014
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A Multi-Centre, Double-Blind, Randomised Comparison Of Seroquel And Haloperidol In The Treatment Of Subjects With Acute Exacerbation Of Subchronic And Chronic Schizophrenia.
schizophrenia
Phase 3
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
-
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|